Douglas Forsyth - Aug 22, 2024 Form 4 Insider Report for Inhibrx Biosciences, Inc. (INBX)

Role
Director
Signature
/s/ Kelly D. Deck, as attorney-in-fact for Douglas G. Forsyth
Stock symbol
INBX
Transactions as of
Aug 22, 2024
Transactions value $
$1,037,328
Form type
4
Date filed
8/26/2024, 04:26 PM
Previous filing
May 30, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INBX Common Stock Purchase $196K +15.2K +10.15% $12.89 165K Aug 22, 2024 By the Forsyth Family Trust Dated July 20, 2001 F1, F2
transaction INBX Common Stock Purchase $842K +59.8K +36.3% $14.07 225K Aug 23, 2024 By the Forsyth Family Trust Dated July 20, 2001 F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were purchased in multiple transactions at prices ranging from $12.80 to $13.00, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F2 The reporting person is a trustee of the Forsyth Family Trust Dated July 20, 2001 and, in such capacity, may be deemed to indirectly beneficially own the securities owned by the Forsyth Family Trust Dated July 20, 2001.
F3 The shares were purchased in multiple transactions at prices ranging from $13.48 to $14.25, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.